financetom
Business
financetom
/
Business
/
BRIEF-Nextracker Announces Acquisition Of Origami Solar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Nextracker Announces Acquisition Of Origami Solar
Sep 8, 2025 1:26 PM

Sept 8 (Reuters) - Nextracker Inc ( NXT ):

* NEXTRACKER ANNOUNCES ACQUISITION OF ORIGAMI SOLAR

* NEXTRACKER BUYS ORIGAMI SOLAR FOR $53 MILLION

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sprott Upsizes Uranium Trust Offering to $200.1 Million
Sprott Upsizes Uranium Trust Offering to $200.1 Million
Jun 16, 2025
10:57 AM EDT, 06/16/2025 (MT Newswires) -- Sprott (SII) said Monday that it amended its agreement with Canaccord Genuity to upsize its underwritten offering of units to $200.1 million. Under the updated agreement, Canaccord will purchase 11.6 million units at $17.25 a piece. Net proceeds from the offering will be used by the Sprott Physical Uranium Trust to acquire uranium...
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial
Jun 16, 2025
Ocugen Inc ( OCGN ) shares are trading higher during Monday’s session after the company received clearance from the U.S. FDA for its Investigational New Drug amendment to start a Phase 2/3 pivotal trial for OCU410ST. What To Know: This candidate is a modifier gene therapy being developed for Stargardt disease, a leading cause of genetic blindness in children and...
AptarGroup Insider Sold Shares Worth $305,606, According to a Recent SEC Filing
AptarGroup Insider Sold Shares Worth $305,606, According to a Recent SEC Filing
Jun 16, 2025
10:58 AM EDT, 06/16/2025 (MT Newswires) -- Marc Prieur, Segment President, on June 13, 2025, sold 2,000 shares in AptarGroup ( ATR ) for $305,606. Following the Form 4 filing with the SEC, Prieur has control over a total of 15,745 common shares of the company, with 15,745 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/896622/000106299325011719/xslF345X05/form4.xml Price: 152.58, Change: +1.42, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved